Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription Articles published in JAMA Retrieve available abstracts of 58 articles: HTML format

Single Articles

October 2026
1. ANDERER S
   Population Living With HIV Projected to Age in Coming Years.
   JAMA. 2026 Oct 9. doi: 10.1001/jama.2026.20016.
   PubMed    
   
   
   September 2026
2. DE AVILA L, AlNaamani KM, Papatheodoridi M, Petta S, et al
   Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.
   JAMA. 2026 Sep 30:e2618491. doi: 10.1001/jama.2026.18491.
   PubMed     Abstract available
   
   
   August 2026
3. PRIOR D, Krishnamurti L
   HIV Status Exclusion in Sickle Cell Gene Therapy.
   JAMA. 2026 Aug 19. doi: 10.1001/jama.2026.15933.
   PubMed    
   
   
   
4. ANDERER S
   First Once-Weekly Oral HIV Treatment Demonstrates Safety and Efficacy.
   JAMA. 2026 Aug 7. doi: 10.1001/jama.2026.12043.
   PubMed    
   
   
   July 2026
5. ANDERER S
   ACOG Releases New HIV Screening and Prevention Guidelines.
   JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.9494.
   PubMed    
   
   
   
6. 
   Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: Research Summary.
   JAMA. 2026 Jul 31:e2614955. doi: 10.1001/jama.2026.14955.
   PubMed    
   
   
   
7. WOODS J, Lebina L, Moller K, Venter WDF, et al
   Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial.
   JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.14762.
   PubMed     Abstract available
   
   
   
8. ABBASI J
   HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.
   JAMA. 2026 Jul 2. doi: 10.1001/jama.2026.12082.
   PubMed    
   
   
   June 2026
9. SHORT WR, Sheth AN, Ciaranello A
   HIV, Pregnancy, and Infant Feeding-Reply.
   JAMA. 2026 Jun 10. doi: 10.1001/jama.2026.6036.
   PubMed    
   
   
   
10. YU X, Zhang Y, Shang A
    HIV, Pregnancy, and Infant Feeding.
    JAMA. 2026 Jun 10. doi: 10.1001/jama.2026.6033.
    PubMed    
    
    
    April 2026
11. COOPER KM, Szymanski LM, David PS, Allen SV, et al
    Prepregnancy Care and Counseling: A Review.
    JAMA. 2026 Apr 20. doi: 10.1001/jama.2026.2888.
    PubMed     Abstract available
    
    
    March 2026
12. SCHWEITZER K
    After a Decade of Progress Against HIV, PrEP Enters a Precarious Era.
    JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1795.
    PubMed    
    
    
    February 2026
13. SHORT WR, Sheth AN, Ciaranello A
    HIV During Pregnancy and Infant Feeding.
    JAMA. 2026 Feb 23. doi: 10.1001/jama.2026.0943.
    PubMed    
    
    
    January 2026
14. ROSE MR, Flexner C, Roy V
    Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
    JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.24404.
    PubMed    
    
    
    December 2025
15. PERSON AK, Kelley CF
    World AIDS Day-At a Crossroads.
    JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.23506.
    PubMed    
    
    
    
16. TU SS, Bonis T, Sinha MS, Slade DH, et al
    Combination-Only Approvals as a Barrier to Affordable HIV Care.
    JAMA. 2025 Dec 1. doi: 10.1001/jama.2025.21935.
    PubMed    
    
    
    November 2025
17. HSU M, Shah A, Jordan A, Gold MS, et al
    Therapeutic Use of Cannabis and Cannabinoids: A Review.
    JAMA. 2025 Nov 26. doi: 10.1001/jama.2025.19433.
    PubMed     Abstract available
    
    
    
18. MAUERMANN ML, Staff NP
    Peripheral Neuropathy: A Review.
    JAMA. 2025 Nov 17. doi: 10.1001/jama.2025.19400.
    PubMed     Abstract available
    
    
    October 2025
19. CHEVALIER FJ, Bacon O, Johnson KA, Cohen SE, et al
    Syphilis: A Review.
    JAMA. 2025 Oct 16. doi: 10.1001/jama.2025.17362.
    PubMed     Abstract available
    
    
    September 2025
20. ASSOUMOU SA, Alexander RN, Miller SE
    Viral Infections Associated With Injection Drug Use.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.13287.
    PubMed    
    
    
    August 2025
21. ANDERER S
    Measles Resurgence Puts People With HIV at Risk.
    JAMA. 2025 Aug 22. doi: 10.1001/jama.2025.11011.
    PubMed    
    
    
    
22. CHAN PA, Nunn AS
    Grant Terminations in the US Threaten HIV Research and Future Progress.
    JAMA. 2025 Aug 21. doi: 10.1001/jama.2025.12688.
    PubMed    
    
    
    
23. ANDERER S
    WHO Recommends Lenacapavir for HIV Prevention in New Guidelines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.10988.
    PubMed    
    
    
    July 2025
24. ANDERER S
    FDA Approves First Twice-Yearly PrEP for Long-Acting HIV Prevention.
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.10325.
    PubMed    
    
    
    
25. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.
    JAMA. 2025 Jul 2:e259894. doi: 10.1001/jama.2025.9894.
    PubMed    
    
    
    
26. COLLINS LF, Cunningham SA, Vaughan CP, Ofotokun I, et al
    Promoting Healthy Aging in People With HIV-Into a New Era.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.9244.
    PubMed    
    
    
    June 2025
27. LANDOVITZ RJ, Molina JM, Buchbinder SP
    Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.11410.
    PubMed    
    
    
    May 2025
28. MAGHSOUDLOU P, Epps SJ, Guly CM, Dick AD, et al
    Uveitis in Adults: A Review.
    JAMA. 2025 May 28. doi: 10.1001/jama.2025.4358.
    PubMed     Abstract available
    
    
    
29. EHRENKRANZ PD, Reid MJA, Doherty M, Kim PS, et al
    Long-Acting HIV Treatment in Low- and Middle-Income Countries: Addressing the Public Health Need.
    JAMA. 2025 May 19. doi: 10.1001/jama.2025.5180.
    PubMed    
    
    
    
30. ANDERER S
    One Million New Pediatric HIV Cases Predicted If PEPFAR Funding Is Cut.
    JAMA. 2025 May 9. doi: 10.1001/jama.2025.6155.
    PubMed    
    
    
    April 2025
31. ANDERER S
    Cuts to HIV Assistance Could Undo Years of Progress.
    JAMA. 2025 Apr 25. doi: 10.1001/jama.2025.4672.
    PubMed    
    
    
    March 2025
32. SPINELLI MA, Heise MJ, Gistand N, Cox C, et al
    HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People With and Without Initial Viremia.
    JAMA. 2025 Mar 6. doi: 10.1001/jama.2025.0109.
    PubMed    
    
    
    February 2025
33. SEAS C, Seas PR, Legua P
    A 25-Year-Old With Verrucous Pustules and Fevers.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28032.
    PubMed    
    
    
    
34. APPA A, Spinelli MA, Javanbakht M, Heise MJ, et al
    Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine.
    JAMA. 2025 Feb 26:e2428618. doi: 10.1001/jama.2024.28618.
    PubMed    
    
    
    January 2025
35. ANDERER S
    Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations.
    JAMA. 2025 Jan 3. doi: 10.1001/jama.2024.26876.
    PubMed    
    
    
    December 2024
36. DEL RIO C, Dzau V
    The Urgent Case for Recommitting to Global HIV/AIDS Goals.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26348.
    PubMed    
    
    
    
37. GANDHI RT, Landovitz RJ, Sax PE, Smith DM, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24543.
    PubMed     Abstract available
    
    
    
38. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
    JAMA. 2024 Dec 1:e2424490. doi: 10.1001/jama.2024.24490.
    PubMed     Abstract available
    
    
    
39. HATLEN TJ, Bender Ignacio R, Daar ES
    Advances in Treatment and Prevention of HIV.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24027.
    PubMed    
    
    
    
40. NIU X, Drain PK
    Is Lenacapavir Needed for Individuals Adherent to Daily Oral PrEP?
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.22995.
    PubMed    
    
    
    October 2024
41. PALEFSKY JM
    Prevention of Anal Cancer in High-Risk Individuals.
    JAMA. 2024 Oct 23. doi: 10.1001/jama.2024.17870.
    PubMed    
    
    
    
42. MANN LM, Zhu W, Huang YA, Kourtis AP, et al
    Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21493.
    PubMed    
    
    
    
43. TITANJI BK, Hazra A, Zucker J
    Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21091.
    PubMed     Abstract available
    
    
    
44. SPINELLI MA, Ngure K, Gandhi M
    Preexposure Prophylaxis (PrEP) for HIV.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.16984.
    PubMed    
    
    
    September 2024
45. MALANI P
    Thirty-Five Years of HIV Research in Africa-An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award.
    JAMA. 2024 Sep 19. doi: 10.1001/jama.2024.19030.
    PubMed    
    
    
    July 2024
46. SCHRIER E, Schwartz HEM, Himmelstein DU, Gaffney A, et al
    Hospital Assets Before and After Private Equity Acquisition.
    JAMA. 2024 Jul 30:e2413555. doi: 10.1001/jama.2024.13555.
    PubMed    
    
    
    June 2024
47. HARRIS E
    AAP Changes Its Breastfeeding Policy for People With HIV in US.
    JAMA. 2024 Jun 14. doi: 10.1001/jama.2024.10335.
    PubMed    
    
    
    
48. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    May 2024
49. HARRIS E
    CDC Warns of Surge in Meningococcal Disease in US.
    JAMA. 2024;331:1614.
    PubMed    
    
    
    
50. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed    
    
    
    April 2024
51. HARRIS E
    WHO Documents Rising Resistance to First-Line HIV Drug.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4497.
    PubMed    
    
    
    March 2024
52. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
    Common Oral Conditions: A Review.
    JAMA. 2024;331:1045-1054.
    PubMed     Abstract available
    
    
    
53. SHETH AN, Momplaisir F, Dumond JB
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA. 2024;331:912-914.
    PubMed    
    
    
    
54. PECK RN, Issarow B, Kisigo GA, Kabakama S, et al
    Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial.
    JAMA. 2024 Mar 6:e242177. doi: 10.1001/jama.2024.2177.
    PubMed     Abstract available
    
    
    
55. AMICO KR
    A Linkage-to-Care Intervention for Hospitalized People With HIV: High Value at Minimal Cost.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.0271.
    PubMed    
    
    
    
56. HARRIS E
    Long-Acting HIV Treatment Superior to Daily Oral Drugs.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1570.
    PubMed    
    
    
    
57. MARRAZZO J, Tao L, Becker M, Leech AA, et al
    HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464.
    PubMed     Abstract available
    
    
    
58. SAX PE, Thompson MA, Saag MS
    Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel.
    JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.2985.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum